Actelion, J&J Return to the Negotiating table

In a surprise twist to one of 2016’s biggest potential health deals, Actelion Ltd. and U.S. drug giant Johnson & Johnson are back at the negotiating table just a week after ending earlier talks. Bloomberg's Jeffrey McCracken reports on "Bloomberg Markets." (Source: Bloomberg)

Rabobank Sees BOJ, PBOC Throwing Liquidity Into Markets
32:50 - Rabobank Financial Markets Research Asia Head Michael Every discusses his outlook for the markets and talks about his investment thoughts. He speaks on "Bloomberg Markets." (Source: Bloomberg)
  • ICICI Bank Bad Debt Ratio Rose to 8%
  • Nissan Sees SUVs Driving Sales
  • Starbucks Spends $1.3 Billion in China